Hepatitis C virus nonstructural protein 5A
Nonstructural protein 5A (NS5A) is a
Structure
NS5A is derived from a large polyprotein that is translated from the HCV genome, and undergoes post-translation processing by
NS5A has three structurally different domains: Domain I was demonstrated to be an alternative dimeric structure by
As a drug target
Many
- FDA-approved:
- Ledipasvir, approved on October 10, 2014 in a fixed-dose combination (FDC) with sofosbuvir
- Ombitasvir, approved on December 19, 2014 in a FDC with paritaprevir and ritonavir, co-packaged with dasabuvir
- Daclatasvir, approved on July 24, 2015
- Elbasvir, approved on January 28, 2016 in a FDC with grazoprevir
- Velpatasvir, approved on June 28, 2016 in a FDC with sofosbuvir and on July 17, 2017 in a FDC with sofosbuvir and voxilaprevir
- Pibrentasvir, approved on August 3, 2017 in a FDC with glecaprevir
- Investigational drugs:
Intragenic complementation
Multiple copies of a polypeptide encoded by a gene often can form an aggregate referred to as a multimer. When a multimer is formed from polypeptides produced by two different mutant alleles of a particular gene, the mixed multimer may exhibit greater functional activity than the unmixed multimers formed by each of the mutants alone. When a mixed multimer displays increased functionality relative to the unmixed multimers, the phenomenon is referred to as intragenic complementation.[citation needed]
NS5A protein is a multimer, a dimer in this case, and intragenic complementation of replication-defective NS5A alleles has been demonstrated by Fridell et al.[10] On the bases of pairwise complementation tests between different NS5A mutant alleles, they identified three complementation groups that were considered to define three distinct and genetically separable functions of NS5A in RNA replication.
See also
References
- ^ PMID 23009750.
- ^ PMID 17400273.
- ^ PMID 15302943.
- ^ PMID 21250384. Retrieved 8 January 2021.
- PMID 26702051.
- PMID 28446668.
- PMID 30089697.
- PMID 31511391.
- PMID 32699091.
- ^ Fridell RA, Valera L, Qiu D, Kirk MJ, Wang C, Gao M. Intragenic complementation of hepatitis C virus NS5A RNA replication-defective alleles. J Virol. 2013;87(4):2320-2329. doi:10.1128/JVI.02861-12